FDA Inspection 1207561 — NVE Pharmaceuticals, Inc.
The FDA completed an inspection of NVE Pharmaceuticals, Inc. on May 24, 2023 in Andover, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 24, 2023
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Andover, NJ (United States)